Clinical

Dataset Information

Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors


ABSTRACT: This study is an open-label, international, multi-center, Phase 2 study in adult patients with recurrent, locally-advanced or metastatic solid tumors, which harbor the NRG1 gene fusion.

DISEASE(S): Lung Cancer,Sarcoma,Colorectal Cancer,Bladder Cancer,Gallbladder Cancer,Pancreatic Cancer,Breast Cancer,Neoplasms,Ovarian Cancer,Uterine Neoplasms,Metastatic Solid Tumor,Gallbladder Neoplasms,Bile Duct Neoplasms,Esophageal Cancer,Bile Duct Cancer,Uterine Cancer,Prostate Cancer,Head And Neck Cancer,Kidney Cancer,Locally Advanced Solid Tumor,Cholangiocarcinoma

PROVIDER: 2338833 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR